NCT00195299View on ClinicalTrials.gov

Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

February 28, 2007

Conditions
Squamous Cell Carcinoma
Interventions
DRUG

Temsirolimus

Trial Locations (1)

71130

Shreveport

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195299 - Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck | Biotech Hunter | Biotech Hunter